Catherine A. Sohn
Director at Altimmune, Inc. (ALT); Director at Maze Therapeutics, Inc. (MAZE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$815
Total bought / sold$2K / $1.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 8SEC | MAZEMaze Therapeutics, Inc. | Sell | 2,493 | $38.62 | $96K | -29.8% |
| Jan 8SEC | MAZEMaze Therapeutics, Inc. | Sell | 26,920 | $39.11 | $1.1M | -30.7% |
| Jan 5SEC | ALTAltimmune, Inc. | Buy | 5001,500 held (+50%) | $4.24 | $2K | -38.4% |
- Buy
Director Catherine A. Sohn bought $2K of ALT at $4.24 — first open-market purchase in our records; raises the stake by 50%.